https://oncdata.com/article/3c98794f-0635-421f-ad72-6b55a6b81149Oncology Data Advisoren2026-11-11T02:49:21.123ZPatients With Refractory iMCD May Respond to a Second IL-6 Inhibitor https://oncdata.com/article/282436ab-b63e-4ecf-be3e-8aef6bab55efOncology Data Advisoren2026-11-11T02:49:21.004ZCSCO and ASCO Joint Guideline for Recurrent and Metastatic Nasopharyngeal Carcinoma https://oncdata.com/article/9dabccd8-46d6-4b2b-9a8e-2951de04dd6fOncology Data Advisoren2026-11-10T22:49:20.566ZOptimizing Immune Checkpoint Inhibitor Selection in Metastatic Clear-Cell Renal Cell Carcinoma https://oncdata.com/article/7d132b44-ced4-46d7-b12b-fc88f3d47321Oncology Data Advisoren2026-11-10T22:49:20.448ZHER2-Directed Therapy in Biliary Tract Cancer https://oncdata.com/article/bdf70ef0-36e9-47ab-89c0-3ce7fca80d28Oncology Data Advisoren2026-11-10T12:49:20.623ZNo Significant PFS Benefit With Imlunestrant in Chinese EMBER-3 Cohort https://oncdata.com/article/e44faeb9-3036-4f8a-8595-4b0d269bc8e8Oncology Data Advisoren2026-11-10T12:49:20.525ZModeling Projects Longer PFS With DVRd in Newly Diagnosed Multiple Myeloma https://oncdata.com/article/29e117a2-42f8-42cd-a259-280720a4c447Oncology Data Advisoren2026-11-10T02:49:28.991ZBruton's Tyrosine Kinase Inhibitors in Primary Immune Thrombocytopenia https://oncdata.com/article/81094c9d-be6f-4aab-9aeb-9c408b324f9dOncology Data Advisoren2026-11-10T02:49:28.942ZPARP Inhibitors in Metastatic Prostate Cancer: Evidence Across mCRPC and mHSPC Disease States https://oncdata.com/article/4c8ec6b7-27bf-4ca5-bc23-099ed96b0392Oncology Data Advisoren2026-11-09T22:49:34.182ZShort-Course Dabrafenib With Trametinib Restores Radioiodine Uptake in Thyroid Cancer https://oncdata.com/article/3883d36f-6d07-416f-8d5b-e0c56474650aOncology Data Advisoren2026-11-09T22:49:34.084ZDose-Dense Nab-Paclitaxel Improves RCB 0/I Rate in HR+/HER2- Breast Cancer https://oncdata.com/article/71f2ed1a-a378-47c7-811a-30b8bd420442Oncology Data Advisoren2026-11-09T12:49:46.382ZLiver and Lung Metastases Impact Progression-Free and Overall Survival in Rare Cancers https://oncdata.com/article/3947a8b1-c525-48d3-9949-d503fbb1a1c2Oncology Data Advisoren2026-11-09T12:49:46.251ZSequencing Trastuzumab Deruxtecan and Sacituzumab Govitecan in Metastatic Breast Cancer